1 routine filing (option exercises, shares withheld for taxes, grants, gifts) is not listed here. Show them
Traded Jul 23 – Jul 29, 2026 · largest single transaction ~$33K
Traded Jan 12 – Jan 13, 2026 · largest single transaction ~$80K
Insider buying
Traded Dec 31, 2025 · filed 5 days later
Since the trade −5.8% · S&P 500 +5.0% · to Nov 19
Bought 15% below the 52-week high, RSI 73, 101% above its 200-day average, 106 points ahead of the S&P 500 over 3 months
The CEO of Greenwich Lifesciences paid $92K out of pocket for Greenwich Lifesciences shares.
Insider buying
Traded Dec 30, 2025 · filed 3 days later
Since the trade −9.7% · S&P 500 +4.2% · to Nov 19
Bought 12% below the 52-week high, RSI 78, 110% above its 200-day average, 117 points ahead of the S&P 500 over 3 months
The CEO of Greenwich Lifesciences paid $63K out of pocket for Greenwich Lifesciences shares.
Insider buying
Traded Dec 18, 2025 · filed 1 day later
Since the trade +59.7% · S&P 500 +5.8% · to Nov 19
Bought 10% below the 52-week high, RSI 74, 21% above its 200-day average
The CEO of Greenwich Lifesciences paid $52K out of pocket for Greenwich Lifesciences shares.
Insider buying
Traded Nov 25, 2025 · filed 3 days later
Since the trade +135.6% · S&P 500 +6.0% · to Nov 19
Bought 44% below the 52-week high, RSI 44, 19% under its 200-day average, 32 points behind the S&P 500 over 3 months
The CEO of Greenwich Lifesciences paid $39K out of pocket for Greenwich Lifesciences shares.
Insider buying
Traded Nov 7, 2025 · filed 5 days later
Since the trade +128.5% · S&P 500 +6.7% · to Nov 19
Bought 42% below the 52-week high, RSI 39, 19% under its 200-day average, 36 points behind the S&P 500 over 3 months
The CEO of Greenwich Lifesciences paid $89K out of pocket for Greenwich Lifesciences shares.
Insider buying
Traded Oct 31, 2025 · filed 4 days later
Since the trade +114.9% · S&P 500 +5.0% · to Nov 19
Bought 38% below the 52-week high, RSI 38, 15% under its 200-day average, 31 points behind the S&P 500 over 3 months
The CEO of Greenwich Lifesciences paid $21K out of pocket for Greenwich Lifesciences shares.
Insider buying
Traded Apr 25, 2025 · filed 4 days later
Since the trade +98.3% · S&P 500 +30.0% · to Nov 19
The CEO of Greenwich Lifesciences paid $36K out of pocket for Greenwich Lifesciences shares.
Insider buying
Traded Apr 17, 2025 · filed 5 days later
Since the trade +121.1% · S&P 500 +36.0% · to Nov 19
The CEO of Greenwich Lifesciences paid $48K out of pocket for Greenwich Lifesciences shares.
Traded Apr 4 – Apr 7, 2025 · largest single transaction ~$48K
Insider buying
Traded Jan 10, 2025 · filed 3 days later
Since the trade +59.9% · S&P 500 +23.3% · to Nov 19
The CEO of Greenwich Lifesciences paid $31K out of pocket for Greenwich Lifesciences shares.
Traded Jan 2 – Jan 7, 2025 · largest single transaction ~$44K
Traded Dec 30 – Dec 31, 2024 · largest single transaction ~$36K
Insider buying
Traded Nov 21, 2024 · filed 4 days later
Since the trade +52.6% · S&P 500 +20.6% · to Nov 19
Greenwich Lifesciences's VP Clinical Reg Affairs paid $13K out of pocket for Greenwich Lifesciences shares. It was the first purchase in over a year.